Novonesis (novozymes)-ADRNVZMY
13F holders, Q4 2024 (December 31)8holders −1
1new positions
2sold out
$56.54avg. 13F price*
At the end of Q4 2024, 8 institutions reported holding Novonesis (novozymes)-ADR (NVZMY) in their 13F filings, down 1 from Q3 2024. 1 opened new positions and 2 sold out. The largest holders were Rhumbline Advisers ($585K), Sterling Capital Management LLC ($354K) and S&co Inc. ($254K).
- Company
- Novonesis (novozymes)-ADR
- Filed as
- NOVOZYMES A/S-UNSPONS ADR (Q4 2024)
- CUSIP
- 670108109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4K |
| Exits | 2 | $302K |
All 13F filers, Q3 2024 → Q4 2024: 371 shares bought and 5,428 shares sold, net −5,057 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Rhumbline Advisers | 0.00% | Add +1.8% | 10,355 | $585K |
| Sterling Capital Management LLC | 0.00% | Reduce -13.9% | 6,255 | $354K |
| S&co Inc. | 0.02% | No change | 4,500 | $254K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -5.7% | 1,832 | $104K |
| GAMMA Investing LLC | 0.00% | Reduce -10.4% | 1,004 | $57K |
| Mar Vista Investment Partners LLC | 0.00% | Add +15.6% | 852 | $48K |
| Brooklyn Investment Group | 0.00% | New | 77 | $4K |
| Copeland Capital Management, LLC | 0.00% | No change | 45 | $3K |
"% of holder's portfolio" is NVZMY's weight in each manager's 13F, not the share of Novonesis (novozymes)-ADR the manager owns.